Amber Yates/ LinkedIn
Jun 25, 2026, 15:46
Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
Amber Yates, Senior Medical Director and Global Medical Affairs Leader at Agios Pharmaceuticals, shared a post on LinkedIn:
“A rare day at Agios headquarters, given my remote work, and a meaningful reminder of our shared purpose.
Being in the room with colleagues collectively focused on making a meaningful difference in the lives of people living with sickle cell disease is both energizing and grounding.
Different perspectives, one mission.
Grateful to be part of a work and a team that keeps patients at the center of everything we do.”
Find more posts featuring Amber Yates on Hemostasis Today.
-
Nov 14, 2026, 16:35Sultan Aydın Aslantaş: A Rare Coexistence of LAHPS and Bloom Syndrome in a Child
-
Nov 14, 2026, 16:27Nicolas Moniotte: Dual-Platform Gene Editing for Haemophilia A
-
Nov 14, 2026, 15:30Patient Selection for Gene Therapy in Transfusion-Dependent β-Thalassemia – EHA
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa